Data as of Jul 25
| -0.105 / -3.83%|
The 1 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +165.15% increase from the last price of 2.64.
The current consensus among 2 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.